跳至主要内容
临床试验/NCT01402427
NCT01402427已完成不适用

Omission of Prophylactic Verapamil Use in Transradial Coronary Interventions

State Health Center, Hungary1 个研究点 分布在 1 个国家目标入组 591 人开始时间: 2011年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
591
试验地点
1
主要终点
Rate of Access Site Conversions

研究概览

简要总结

Background Verapamil is traditionally applied prophylactically in transradial procedures to prevent radial artery spasm. However, verapamil may have side effects and is contraindicated in some clinical settings.

Methods: During an investigator-initiated, randomized, double-blind trial, we evaluate the need for preventive verapamil administration. After vascular access is established, patients receive either 5 mg verapamil (n=297) or placebo (n=294). We compare the rate of access site conversions as primary end point using a superiority margin of 5%. Occurrence of code breaks (composite of conversions and unplanned use of verapamil), overall verapamil use, procedural and fluoroscopic times, contrast volume, and subjective pain are investigated as secondary end points.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing transradial coronary angiography and/or percutaneous coronary intervention
  • successful cannulation of the radial artery

排除标准

  • reduced left ventricular systolic function (LVEF<35%)
  • significant aortic stenosis
  • bradycardia (<50/min.)
  • myocardial infarction complicated by cardiogenic shock and/or high grade AV block

研究组 & 干预措施

Verapamil

Active Comparator

干预措施: Verapamil (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Rate of Access Site Conversions

时间窗: Occurrence of access site conversion will be assessed within 1 minute after completion of coronary angiography or intervention.

次要结局

  • Rate of Code Breaks(Occurrence of code breaking will be assessed within 1 minute after completion of coronary angiography or intervention.)
  • Rate of Vasodilator Use(Vasodilator use will be assessed within 1 minute after completion of coronary angiography or intervention.)
  • Procedural Time(Procedural time will be assessed within 1 minute after completion of coronary angiography or intervention.)
  • Fluoroscopic Time(Fluoroscopic time will be assessed within 1 minute after completion of coronary angiography or intervention.)
  • Contrast Volume(The amount of contrast medium will be assessed within 1 minute after completion of coronary angiography or intervention.)
  • Subjective Pain(Subjective pain will be assessed within 1 minute after completion of coronary angiography or intervention.)

研究者

发起方
State Health Center, Hungary
申办方类型
Other
责任方
Principal Investigator
主要研究者

Istvan Hizoh, MD, PhD

Senior Consultant

State Health Center, Hungary

研究点 (1)

Loading locations...

相似试验